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Abstract This report is on recovery and long-term out-
comes in a small-scale randomised controlled trial (RCT)
after total laparoscopic hysterectomy versus total abdominal
hysterectomy in (potential) endometrial carcinoma patients.
An RCT was performed among women with atypical
endometrial hyperplasia and endometrial carcinoma
scheduled for hysterectomy in a teaching hospital in
The Netherlands. Women were randomised to total
laparoscopic hysterectomy versus total abdominal hysterec-
tomy both with bilateral salpingo-oophorectomy and
were followed until 5 years after the intervention.
Patients completed the RAND 36-Item Short Form
Health Survey (RAND-36), Quality of Recovery-40
(QoR-40) and Recovery Index-10 (RI-10) until 12 weeks
after surgery. Main outcome measure was quality of life
and recovery in the first 12 weeks after surgery. A linear
mixed model was used for statistical analysis while
accounting for baseline values where applicable. Seven-
teen women were included, of whom 11 allocated to the
laparoscopic arm and 6 to the abdominal arm. Laparo-
scopic hysterectomy performed better on all scales and
subscales used in the study. A statistically significant
treatment effect, favouring laparoscopic hysterectomy,
was found in the total RAND-36 (difference between
groups 142 units, 95% confidence interval 46; 236).
Clinical follow-up was completed after median
60 months, but this study was too small for conclusions
regarding the safety and survival. Laparoscopic hysterec-
tomy results in better postoperative quality of life in the
first 12 weeks after surgery when compared with
abdominal hysterectomy.
Keywords Abdominal hysterectomy . Endometrial
carcinoma . Laparoscopic hysterectomy . Randomised .
Recovery . Quality of life
Background
Different approaches to hysterectomy have been extensively
studied for the benign indications, and randomised controlled
trials (RCTs) have been summarized in systematic review and
meta-analysis [1]. One of the important results was a
significant 2.6-fold increased risk of urinary tract injury.
Recovery and quality of life were shown to be better after
laparoscopic hysterectomy [2, 3]. In malignant disease,
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however, clinical outcomes such as complication rates or
postoperative recovery may be different from the benign
indications. The women are generally older, and the uterus is
mostly smaller and less vascularised. And recurrence rate
and survival rate are probably the most important long-term
outcomes in these women.
At this moment, there are eight RCTs [4–12] available
comparing laparoscopic and abdominal hysterectomy in
(potential) endometrial carcinoma patients. Four RCTs [4–
7] have been summarized in a systematic review in 2008
[13] and four further RCTs are available since then [8–12].
Quality of life was an outcome measure in four studies
on 1,526 women [5, 9–11]. The laparoscopic approach was
favourable in all studies, although this difference proved to
be not clinically relevant in one study [9]. Better quality-of-
life scores were found up till 3 months in one study [10]
and up till 6 months after surgery in two further studies
[5, 11].
Only two study groups on previous RCTs have already
analysed the recurrence and survival rates by treatment
group with 3 [4] and 6 years [12] median follow-up. These
studies showed similar rates after laparoscopic and abdominal
hysterectomy among 206 women. Data on recurrence and
survival from the three large RCTs that have recently closed
the inclusion on another 1,442 women are awaited with
interest [9–11]. Future systematic review and meta-analysis
of RCTs will provide a reliable answer to the question
whether laparoscopic hysterectomy is a safe approach in
women with endometrial cancer.
In the present paper, the results of a small RCT
comparing total laparoscopic hysterectomy and total ab-
dominal hysterectomy in women with atypical endometrial
hyperplasia and endometrial carcinoma are presented.
Postoperative quality of life as measured by the RAND-
36 health survey and long-term clinical outcomes, including
recurrence rates until 5 years after the intervention, have
been assessed.
Methods
Participants
This study was performed in the Maxima Medical Centre, a
large teaching hospital in the south of The Netherlands,
from August 2002 through January 2005. The gynaecologic
department is experienced in minimal invasive surgery,
with 10 years experience in laparoscopic hysterectomy
before the start of the study.
Patients were eligible for the study in case there was no
suspicion of endometrial carcinoma beyond FIGO stage 1,
and the size of the uterus did not exceed 18 weeks of
gestation. Chest X-ray was performed in all women, but no
routine hysteroscopy was performed for preoperative
staging. Exclusion criteria were a previous lower abdominal
midline incision, the need for simultaneous interventions
and inability to speak Dutch. Approval for the study was
obtained from the ethics committee of the Maxima Medical
Centre on July 25, 2002 under number 0217. There is no
overlap of the population with other published Dutch
studies [3, 10]. Written informed consent was required for
participation. The study was performed in line with the
CONSORT statement.
Peritoneal fluid or cytological washing from the abdominal
cavity was sent for pathology, but no standard peritoneal
biopsies or lymphadenectomy was carried out in either group.
No frozen sections were planned or performed. The laparo-
scopic procedures were total laparoscopic hysterectomies
(TLH), where the operation of the vaginal part was restricted
to the removal of the laparoscopically freed uterus, and the
vaginal vault was sutured laparoscopically [2]. In laparo-
scopic hysterectomy, the uterus was manipulated by the
Karl Storz Clermont-Ferrand manipulator (Karl Storz,
Tuttlingen, Germany) after cauterization of the fallopian
tubes to avoid spillage of cancer cells. In abdominal
hysterectomy, the uterus was manipulated with the use of
two Heaney clamps placed over the fallopian tube–ovarian
ligament complex on both sides. There was an equal
dissection of pelvic tissues in the laparoscopic as com-
pared with the open technique.
The primary outcome of this study was quality of life.
Three questionnaires have been used in the study: the
RAND-36 health survey (RAND-36), Quality of Recovery-
40 (QoR-40) and Recovery Index-10 (RI-10). The three
questionnaires have previously been validated for the Dutch
language [14, 15]. The RAND-36 is a generic health-related
quality-of-life questionnaire. The questionnaire measures
subjective health in eight scales, which range from 0 to 100.
Thus, the total score ranges from 0 to 800, where 0 is the
poorest quality of life and 800 the best imaginable.
Summated ratings and standardized scoring algorithms
were used to assess the eight scales [14]. The QoR-40 and
RI-10 are postoperative recovery-specific questionnaires
[15]. The QoR-40 consists of 40 items in five subscales:
emotional state, physical comfort, psychological support,
physical independence and pain. Each item was answered
on a five-point Likert scale, ranging from none of the time
to all the time. The QoR-40 score was defined as the sum of
the scores of all items. The QoR-40 score ranged from 40 to
200, in which 200 indicates a perfect recovery. The items
referred to the past 24 h and aimed at patients during
hospital stay, but could be filled out at home as well. The
RI-10 is a ten-item questionnaire measuring postoperative
recovery on five-point Likert scales ranging from full
disagreement to full agreement. The instrument has no
separate subscales, and the score ranges from 10 to 50,
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where 50 indicates a perfect recovery. The items referred to
the past week. Since most of the items in the RI-10 referred
to the postoperative situation, no baseline measurement was
available. The items suited best for recently discharged
patients, but could be filled out in hospital as well.
Patients filled out the questionnaires without assistance of
the researcher and returned the questionnaires by mail. The
baseline measurement was completed after randomisation.
Measurement moments were as proposed for surgical studies
in the previous validation study [15].
The surgical outcome (peri and postoperative clinical
outcome) and oncological outcome (recurrence and survival
rates) were secondary outcome measures of the study.
FIGO nomenclature (Rio de Janeiro 1988) was used to
describe surgical cancer stages. The decision for postoperative
external beam pelvic radiotherapy was made as based on the
PORTEC trial [16]. Data were collected by completion of a
standardized case record form. At the end of follow-up in the
present study (June 2008), all patients were interviewed on
any adverse outcomes or events from the condition or
surgery. In case no written reply was received, telephone
calls were made to complete these data.
Sample size and randomisation
The study has been performed parallel to a larger study on
laparoscopic versus abdominal hysterectomy in benign con-
ditions [2]. For that study, the sample size was calculated for
the quality of life as measured by the questionnaire RAND-
36. A difference of 15 per scale was considered as clinically
relevant. With a standard deviation of 20, a type I error of
0.05, and 80% power, 28 patients were needed per arm.
After obtaining written informed consent, randomisation
took place by opening numbered, sealed opaque envelopes.
For concealment, an independent person had randomly
assigned an equal number of 38 papers with either
intervention to the envelopes. The closed envelopes were
shuffled before numbering, and were used for both patients
with benign and malignant disease. The patients and
medical team were not blinded to the intervention.
Statistical methods
The data are presented on intention-to-treat basis. The
medians with the range are presented in case of continuous
data and absolute numbers with percentages in case of
dichotomous variables. Differences in medical outcome
between the two treatment groups were tested for statistical
significance using the Mann–Whitney U test in case of
continuous data, and the Fisher's exact test in case of two
by two tables. A linear mixed model was used to study the
differences in scores on the questionnaires between the
laparoscopic and abdominal group over time while
accounting for the baseline values for each of the scales
and subscales separately [17]. The dependent variable was
the (sub)scale of RAND-36, QoR-40 or RI-10. The
independent class variables were patient and treatment
(laparoscopic and abdominal hysterectomy, respectively)
and time since surgery, and the independent regression
variables was the baseline level. Both the intercept and the
regression in time of each patient were treated as random
variables in the model. This way differences between
treatments are estimated given the baseline value, while
differences in recovery among patients are allowed.
Initially, interaction terms and quadratic terms in time were
included in the linear part of the model; but as the inclusion
did not significantly (likelihood-ratio test) improve the fit to
the data, these terms were not included in the final model used
[17]. Note that excluding the interaction term of group with
time, results in a parallel line model, (i.e. the differences
between groups are identical at each point of measurement).
The estimated regression parameters with standard errors of
each score are used to calculate the average level per week
of the patients in each group. These levels with confidence
bands are further presented in figures.
The quality-of-life data were analysed by SAS 8.2 software
(SAS Institute, Inc., Chicago, IL, USA), all other data in SPSS
16.0 software (SPSS, Inc., Chicago, IL, USA), with p
values <0.05 considered statistically significant.
Findings
Seventeen women were randomised, of whom 11 were
allocated to the laparoscopic arm and 6 were allocated to
the abdominal arm. Patient characteristics and surgical
indications are shown in Table 1. A flowchart of the study
is presented in Fig. 1. Overall median clinical follow-up
after the operation was 60 months (range 18–81 months)
until the last gynaecological examination. The interviews
on any adverse outcomes were minimum 45 months after
surgery (median 65 months, range 45–81 months). No
women were lost to follow-up.
The surgical and oncological outcome
Data on the procedures including histological findings are
presented in Table 2. There was one intra-operative
conversion from laparoscopy to laparotomy, which was
related to difficult access due to adiposity and 300 mL
blood loss during laparoscopy. Her recovery and follow-
up were uneventful. All other laparoscopic hysterecto-
mies were performed as TLH. There was no macroscopi-
cally visible or palpable tumour extra-uterine tumour in
either group. All final histologies showed endometroid
type adenocarcinoma, except in a woman with FIGO
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stage 3a grade 2 in the laparoscopic hysterectomy group,
who had a mixed-cell type tumour (endometroid and
serous adenocarcinoma).
Complications by treatment group are presented in
Table 3. In one patient, randomised to abdominal
hysterectomy, final histology demonstrated that the cervix
had not been removed completely in a woman with
atypical endometrial hyperplasia. It has been decided not
to perform a reoperation. Her follow-up has been
uneventful, besides a tension-free vaginal tape (TVT)]
procedure, which has been performed due to deterioration
of stress urinary incontinence 2 years postoperatively.
Other complications in the abdominal hysterectomy
group were: 1,450 mL blood loss during surgery, one
woman with temporary atrial flutter, one woman with
temporary low oxygenation, a urinary tract infection and
fever of unknown origin in the immediate postoperative
period. One woman developed radiation colitis after
radiotherapy.
In the laparoscopic hysterectomy group, two women
died because of a recurrent endometrial carcinoma. Of these
two women, one was a 57-year-old woman with Figo stage
1c grade 2 disease, and no postoperative radiotherapy had a
locoregional recurrence 12 months after surgery and
died 2 months later. A stent was inserted for bowel
obstruction, but the extensiveness of the metastases and
her general condition did not allow for any adjuvant
therapy. The other was a 64-year-old woman with the
mixed cell-type tumour stage 3a grade 2 underwent
pelvic radiotherapy and had a recurrence 11 months
after surgery. Her general condition did not allow for
adjuvant chemotherapy, and she died 18 months after
surgery. Other complications in the laparoscopic hys-
terectomy group were a urinary tract infection, deteri-
oration of pre-operative micturition problems with long-
term catheterization, back pain for which a neurologist
was consulted but found no abnormalities. One woman
developed radiation colitis after radiotherapy. No other
complications (such as blood transfusions, visceral
damage or port-site metastasis) occurred in either
group.
Quality of life and recovery
Overall, only four questionnaires were missing, and thus,
the return rate of the questionnaires was 97%. Table 4 and
Fig. 2a, b and c show the differences in total scores on the
three questionnaires between laparoscopic and abdominal
hysterectomy. No scale or subscale was in favour of
abdominal hysterectomy. The difference between groups in
Fig. 1 Flowchart of the study
Table 1 Patient characteristics and surgical indications by treatment
group
LH (n=11) AH (n=6)
Age (years) 59 [49–69] 64 [59–73]
BMI (kg/m2) 27 [21–50] 27 [21–32]
Parity 2 [0–4] 2 [0–6]
ASA score 2 [1–3] 1 [1–2]
Uterine weight (g) 100 [50–175] 75 [50–280]
Indication for surgery
Atypical hyperplasia 3 (27%) 2 (33%)
Endometrial carcinoma 8 (73%) 4 (66%)
Baseline RAND-36 581 [366–744] 670 [278–726]
QoR-40 183 [147–200] 184 [157–200]
RI-10 n.a. n.a.
Data presented as median [range] or absolute numbers (percentage)]
AH abdominal hysterectomy, ASA American Society of Anesthesiol-
ogists, BMI body mass index, LH laparoscopic hysterectomy, RAND-
36 RAND 36-Item Short Form Health Survey, QoR-40 Quality of
Recovery-40, RI-10 Recovery Index-10, n.a. not applicable
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Eligible patients: not registered
Consent for randomisation: 17 women
LH= 11women AH= 6 women
Baseline
1 day 11
2 days 11
3 days 11
1 week 11
2 weeks 10
4 weeks 10
6 weeks 10
12weeks 10
Baseline 6
1 day 6
2 days 6
3 days 6
1 week 6
2 weeks 6
4 weeks 6
6 weeks 6
12 weeks 6
5 years:
Recurrence or deceased 0
Follow up complete 5
5 years:
Recurrence anddeceased 2
Follow up complete 9
11
the RAND-36 total score was 142 units (95% confidence
interval (CI) 46; 236) in favour of laparoscopic hysterectomy.
Furthermore, in three RAND-36 subscales relating to
physical well-being, statistically significant treatment
effects in favour of laparoscopic hysterectomy were
found (data not shown). One QoR-40 subscale and the
total RI-10 showed borderline significant differences.
Note that the difference between the treatment groups are
presented after correction for differences in baseline
values between the groups. The estimated increase per
10 units higher level in the total RAND-36 score at
baseline between two patients was 7 (95%CI 4; 11) units.
This was independent of both timepoint and treatment
group. Furthermore, the estimated increase in the total
RAND-36 score at 12 weeks after surgery compared with
1 week after surgery was 122 (95% CI 67; 178) units in
both groups.
Conclusions
In this RCT, the difference in recovery was assessed
between total laparoscopic hysterectomy and total abdominal
hysterectomy, both with bilateral salpingo-oophorectomy, in
patients scheduled for hysterectomy for reason of atypical
endometrial hyperplasia or endometrial carcinoma. After
baseline correction, we report a statistically significant
difference in postoperative quality of life as measured by
RAND-36, favouring laparoscopic hysterectomy. This differ-
ence between the treatment groups was present all along the
Table 2 Data on surgical procedures and oncological outcome by treatment group
LH (n=11) AH (n=6) P value
Intra-operative laparoconversion 1 (9%) n.a. n.a.
Operation time (min) 122 [96–168] 80 [70–192] 0.03
Blood loss (mL) 200 [0–550] 350 [300–1450] 0.01
Hospitalization (days) 5 [4–16] 8 [5–11] 0.03
Clinical follow-up (months) 54 [18–80] 64 [50–81] 0.09
Diseased after recurrence 2 (18%) 0 0.40
Postoperative histology
Normal 1 (9%) 0
Atypical hyperplasia 0 1 (17%)
Endometrial carcinomaa 10 (91%) 5 (83%) 0.60
Postoperative radiotherapy 3 (27%) 3 (50%) 0.34
Data shown as absolute numbers (percentage) or median [range]. p = p value for differences between groups using Fisher's exact test in cases of 2-
by-2 tables, and Mann–Whitney test in cases of non-normal distributed numerical variables
AH abdominal hysterectomy, LH laparoscopic hysterectomy, n.a. not applicable
a Endometrial carcinomas were stage 1b grade 1 (2 patients), 1c grade 1, 2a grade 1, and 3a grade 1 in the AH group, and 1a grade 1, 1b grade 1 (3
patients), 1b grade 2, 1c grade 1, 1c grade 2 (2 patients), 2b grade 1 and 3a grade 2 in the LH group. All histologies showed endometroid type
adenocarcinoma, except one woman in the LH group with stage 3a grade 2 mixed cell-type tumour (endometroid and serous adenocarcinoma)
LH (n=11) AH (n=6) P value
Blood loss >1,000 cm3 0 1 (17%) 0.35
Fever (unknown origin) 0 1 (17%) 0.35
Urinary tract infection 1 (9%) 1 (17%) 1.0
Cervical stump problems 0 1 (17%) 0.35
Urinary symptoms 1 (9%) a 1 (17%) b 1.0
Temporary low saturation 0 1 (17%) 0.35
Atrial flutter 0 1 (17%) 0.35
Back pain 1 (9%) 0 1.0
Radiation colitis 1 (33%) c 1 (33%) c 1.0
Total complications 4 8 n.a.
No of patients with complications 3 (27%) 5 (83%) 0.05
Table 3 Complications by
treatment group
AH abdominal hysterectomy, LH
laparoscopic hysterectomy, n.a.
not applicable
Data shown as absolute numbers
(percentage). p = p value for
difference between groups using
Fisher's exact test
a Deterioration stress urinary in-
continence
b TVT increased residual urine
with self-catheterization
c Note that three women in each
group received radiotherapy
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recovery period until 12 weeks after surgery. All subscales of
RAND-36 and QoR-40, as well as the RI-10, showed a
favourable outcome after laparoscopic hysterectomy com-
pared with abdominal hysterectomy. This is in agreement with
other studies on quality of life after surgery in (potential)
endometrial carcinoma patients [5, 9–11] and our previous
findings in a larger benign population [2]. We found that
the laparoscopic procedure took longer to perform, but
with regard to other surgical and oncological outcomes,
the present study is limited by its small sample size. These
data may however be useful in future meta-analysis on the
topic.
Lymphadenectomy has not been performed in this
study amongst women with clinical stage I disease with
expected low-grade endometrial carcinoma based on
endometrial biopsy. Recently, two RCTs have failed to
demonstrate any advantage over routine lymphadenec-
tomy in endometrial carcinoma patients [18]. Nonethe-
less, routine lymphadenectomy in endometrial carcinoma
is still under debate [19]. It is common practice throughout
the Netherlands to perform hysterectomy and bilateral
salpingo-oophorectomy in these women and advice post-
operative radiotherapy as based on the PORTEC studies
[16, 20]. Thus, the results from our trial are limited to the
population undergoing this type of treatment. Furthermore,
note that PORTEC-2 data were not yet available at the
time of the study [21], and no vaginal brachytherapy has
been applied in the study.
In hysterectomies performed for potential malignant
indications, recurrence and survival rates are of utmost
importance. Although, there are no indications that lapa-
roscopy is less safe [5, 12], this has not definitively been
proven until now. In the present study, two women in the
laparoscopic arm had a recurrence and died due to their
malignancy. One woman had a bad prognosis due to a high-
stage mixed cell tumour. In line with the PORTEC study,
the other woman had not received postoperative radiotherapy
to minimize her risk of locoregional recurrence. With a FIGO
stage 1c grade 2 and aged 57 years, she was, however, rather
close to the range of less favourable prognostic factors with
indication for radiotherapy.
Not only the route of hysterectomy, e.g. abdominal or
laparoscopic hysterectomy, may influence recurrence
rates and all other potential factors should thus be
reported in according studies. In the present study, for
example, an intra-uterine manipulator has been used. The
impact on outcomes as compared with, e.g. vaginal
manipulation with a tube only is not known until now.
In two previous studies on peritoneal washings before
and after manipulation with an intra-uterine device,
spread of malignant cells could be demonstrated in 2
out of 82 women with negative peritoneal washings prior
to manipulation [22, 23]. Only one of these two women
has sufficiently long follow-up (28 months) to report that
no recurrence of malignancy has occurred [23]. Another
histological phenomenon, “vascular pseudo invasion” of
tumour into the blood vessels, has been described after
manipulation with an intra-uterine balloon causing high
intra-uterine pressures. Since this may have consequences
for the staging and further therapy, this phenomenon may
be regarded as undesirable and awareness among pathol-
ogists is needed [24].
The finding that quality of life was better after laparo-
scopic hysterectomy goes hand in hand with a different
spectrum of complications as compared with other types of
hysterectomy. A meta-analysis on benign indications
reported a significant 2.6-fold increased risk of urinary tract
injury [1]. Whether this also applies to endometrial
Table 4 Estimated increase in questionnaire score level (95%
confidence interval) by treatment group, by unit increase in baseline
score and point of measurement using a linear mixed model
RAND-36 QoR-40 RI-10
Treatment groupa
LH 142 (46; 236) 9 (−3; 21) 7 (0; 14)
AH 0 (reference) 0 (reference) 0 (reference)
Baseline effect
per 10 unitsb 7 (4; 11) 5 (1; 9) n.a.
Time after surgery
1 day n.a. 0 (reference) n.a.
2 days n.a. 4 (−3; 12) n.a.
3 days n.a. 4 (−4; 11) n.a.
1 week 0 (reference) 13 (6; 20) 0 (reference)
2 weeks −8 (−64; 47) 26 (18; 33) 0 (−3; 2)
4 weeks 49 (−6; 105) n.a. 4 (1; 6)
6 weeks 130 (74; 185) n.a. 6 (4; 9)
12 weeks 122 (67; 178) n.a. 8 (5; 11)
Example: On average, the estimated level of the total RAND-36 score
in the LH group was 142 units higher as compared with the AH group,
at each timepoint from 2 to 12 weeks after surgery. The estimated
increase per 10 units higher level in the total RAND-36 score at
baseline between two patients was 7 units. This was independent of
both timepoint and treatment group. Furthermore, the estimated
increase in the total RAND-36 score at 12 weeks after surgery,
compared to 1 week after surgery, was 122 units in both groups
Because the data fit very well to the parallel-line model the differences
over time after surgery is estimated to be identical in both groups (see
also Fig. 2a, b and c)
LH laparoscopic hysterectomy, AH abdominal hysterectomy, RAND-
36 RAND 36-Item Short Form Health Survey, QoR-40 Quality of
Recovery-40, RI-10 Recovery Index-10, n.a. not applicable
a Difference between groups after correction for baseline differences
b The baseline effect is the increase in postoperative score per 10 units
increase at baseline
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carcinoma patients has not yet been unravelled, and cannot
be concluded from the present study. The incidence of
major complications in laparoscopic hysterectomy may,
however, be highly reduced with experience of the surgeon.
In Finland, the incidence of urinary tract injury in
laparoscopic hysterectomy decreased from 1.4% to 0.7%
in recent years [25]. Ureteral damage now happens in only
0.3% of cases, which seems comparable to abdominal
hysterectomy. Dependent on patient preference, the poten-
tial risks should be weighed against the improved quality of
life after surgery in individual cases.
The conclusion from this small RCT was that laparo-
scopic hysterectomy was associated with better quality of
life in the recovery period as compared to abdominal
hysterectomy in women with atypical endometrial hyper-
plasia and endometrial carcinoma.
Fig. 2 a, b and c. The mean levels of the questionnaire scores after
surgery by treatment group. The symbols indicate the observed mean
and the vertical bars indicate ±one standard deviation. The thick lines
indicate the estimated mean profiles and the thin, short dashed lines
indicate the appropriate 95% confidence bands using a linear mixed
model that accounts for the baseline value. Women in the laparoscopic
hysterectomy group: dot, solid line. Women in the abdominal
hysterectomy group: star, thick dashed line. RAND-36 RAND 36-
Item Short Form Health Survey, QoR-40 Quality of Recovery-40, RI-
10 Recovery Index-10. Note that the data fit very well to the parallel-
line model
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